These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 34125420)

  • 1. Antimicrobial Dose Reduction in Continuous Renal Replacement Therapy: Myth or Real Need? A Practical Approach for Guiding Dose Optimization of Novel Antibiotics.
    Gatti M; Pea F
    Clin Pharmacokinet; 2021 Oct; 60(10):1271-1289. PubMed ID: 34125420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, Pharmacodynamics, and Dose Optimization of Cefiderocol during Continuous Renal Replacement Therapy.
    Wenzler E; Butler D; Tan X; Katsube T; Wajima T
    Clin Pharmacokinet; 2022 Apr; 61(4):539-552. PubMed ID: 34792787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of Commonly Used Medications in Children Receiving Continuous Renal Replacement Therapy: A Systematic Review of Current Literature.
    Dubinsky S; Watt K; Saleeb S; Ahmed B; Carter C; Yeung CHT; Edginton A
    Clin Pharmacokinet; 2022 Feb; 61(2):189-229. PubMed ID: 34846703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic target attainment in critically ill renal patients on antimicrobial usage: focus on novel beta-lactams and beta lactams/beta-lactamase inhibitors.
    Gatti M; Pea F
    Expert Rev Clin Pharmacol; 2021 May; 14(5):583-599. PubMed ID: 33687300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy.
    Pea F; Viale P; Pavan F; Furlanut M
    Clin Pharmacokinet; 2007; 46(12):997-1038. PubMed ID: 18027987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy.
    Ulldemolins M; Vaquer S; Llauradó-Serra M; Pontes C; Calvo G; Soy D; Martín-Loeches I
    Crit Care; 2014 Jun; 18(3):227. PubMed ID: 25042938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy.
    Kalaria S; Williford S; Guo D; Shu Y; Medlin C; Li M; Yeung SYA; Ali F; Jean W; Gopalakrishnan M; Heavner M
    Pharmacotherapy; 2021 Feb; 41(2):205-211. PubMed ID: 33438291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftolozane/tazobactam exposure in critically ill patients undergoing continuous renal replacement therapy: a PK/PD approach to tailor dosing.
    Gatti M; Giannella M; Raschi E; Viale P; De Ponti F
    J Antimicrob Chemother; 2021 Jan; 76(1):199-205. PubMed ID: 33057628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, Pharmacodynamics, and Dosing Considerations of Novel β-Lactams and β-Lactam/β-Lactamase Inhibitors in Critically Ill Adult Patients: Focus on Obesity, Augmented Renal Clearance, Renal Replacement Therapies, and Extracorporeal Membrane Oxygenation.
    Bakdach D; Elajez R; Bakdach AR; Awaisu A; De Pascale G; Ait Hssain A
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
    Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRRT prescription and delivery of dose.
    Neyra JA; Tolwani A
    Semin Dial; 2021 Nov; 34(6):432-439. PubMed ID: 33909931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Guide to Understanding Antimicrobial Drug Dosing in Critically Ill Patients on Renal Replacement Therapy.
    Pistolesi V; Morabito S; Di Mario F; Regolisti G; Cantarelli C; Fiaccadori E
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents.
    Bader MS; Loeb M; Leto D; Brooks AA
    Postgrad Med; 2020 Apr; 132(3):234-250. PubMed ID: 31608743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections.
    Sader HS; Castanheira M; Duncan LR; Mendes RE
    Int J Infect Dis; 2021 Dec; 113():279-281. PubMed ID: 34670144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefiderocol Dosing for Patients Receiving Continuous Renal Replacement Therapy.
    Wei X; Naseer S; Weinstein EA; Iarikov D; Nambiar S; Reynolds KS; Jang SH
    Clin Pharmacol Ther; 2022 Nov; 112(5):1004-1007. PubMed ID: 35792715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of meropenem in critically ill patients undergoing continuous renal replacement therapy.
    Isla A; Rodríguez-Gascón A; Trocóniz IF; Bueno L; Solinís MA; Maynar J; Sánchez-Izquierdo JA; Pedraz JL
    Clin Pharmacokinet; 2008; 47(3):173-80. PubMed ID: 18307371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal Detection of MB-102 and Correlation to Meropenem Pharmacokinetics During Continuous Renal Replacement Therapy: In Vivo Results.
    Dorshow RB; Johnson JR; Shieh JJ; Riley IR; Rogers TE; Pino CJ; Johnston KA; Tang P; Nolin TD; Humes HD; Goldstein SL
    ASAIO J; 2023 Jul; 69(7):708-715. PubMed ID: 37097973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Regimens of Novel Antibiotics in Critically Ill Patients with Varying Renal Functions: A Rapid Review.
    Gorham J; Taccone FS; Hites M
    Antibiotics (Basel); 2022 Apr; 11(5):. PubMed ID: 35625190
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review of Linezolid Pharmacokinetics/Pharmacodynamics in Patients Undergoing Continuous Renal Replacement Therapy: Does One Size Fit All?
    Liu Y; Ge XH; Guo HL; Chen F; Zhang Y; Xu J; Ji X; Miao HJ
    Curr Drug Metab; 2023; 24(1):70-77. PubMed ID: 36579392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of trimethoprim/sulfametrole in critically ill patients on continuous renal replacement therapy.
    Welte R; Beyer R; Hotter J; Broeker A; Wicha SG; Gasperetti T; Ranke P; Zaruba MM; Lorenz I; Eschertzhuber S; Ströhle M; Bellmann-Weiler R; Joannidis M; Bellmann R
    J Antimicrob Chemother; 2020 May; 75(5):1237-1241. PubMed ID: 31990343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.